LYNPARZA® in Combination With Bevacizumab, and as Monotherapy, Demonstrates Clinically Meaningful Long-Term Survival in Certain Patients With First-Line Advanced Ovarian Cancer in Exploratory Analyses of Two Phase 3 Trials Life Science Investing
Bausch Health Responds to Norwich Pharmaceuticals Tentative FDA Approval for a 200 mg Rifaximin Pharmaceutical Investing
FDA and EMA Accept Regulatory Submission for Pfizer's Ritlecitinib for Individuals 12 Years and Older with Alopecia Areata Life Science Investing
Bausch Health Clarifies Release Provisions Related to its Exchange Offers and Consent Solicitations Pharmaceutical Investing
Merck Foundation Launches $20 Million Initiative to Advance Equity in U.S. Cancer Care Life Science Investing
Three-Year Data on World's Smallest Heart Device Show Benefits of Fixing Holes in Newborn Hearts Without Surgery Pharmaceutical Investing
Love Pharma's Investment in US Biotech Offers Strategic Industry Advantages and Enhanced Shareholder Value Pharmaceutical Investing
New MEASURE-AD Analyses Evaluate Clinical, Psychosocial and Economic Burdens in Atopic Dermatitis Patients Pharmaceutical Investing
AbbVie to Present Data From its Robust Migraine Portfolio at the Migraine Trust International Symposium 2022 Pharmaceutical Investing
Trodelvy® Significantly Improved Overall Survival in Pre-Treated HR+/HER2- Metastatic Breast Cancer Patients in TROPiCS-02 Study Pharmaceutical Investing
